Albulescu LO, Sabet N, Gudipati M, Stepankiw N, Bergman ZJ, Huffaker TC, Pleiss JA (2012). A quantitative high-throughput reverse genetic screen reveals novel connections between Pre-mRNA splicing and 5′ and 3′ end transcript determinants. PLoS Genet. 8(3):e1002530.
Crossref

Anders S, Reyes A, Huber W (2012). Detecting differential usage of exons from RNA-seq data. Genome Res. 22(10):2008-2017.
Crossref

Anders S, Pyl PT, Huber W (2015). HTSeq A Python framework to work with high-throughput sequencing data. Bioinformatics 31(2):166-169.
Crossref

Cancer Genome Atlas (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330-337.
Crossref

Chandramohan R, Wu PY, Phan H, Wang MD (2013). Benchmarking RNA-Seq quantification tools. Conf. Proc. IEEE Eng. Med. Biol. Soc. pp. 647-650.
Crossref

Chen D, Sun Y, Wei Y, Zhang P, Rezaeian AH, Teruya-Feldstein J, Gupta S, Liang H, Lin HK, Hung MC, Ma L (2012). LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat. Med. 18(10):1511-1517.
Crossref

Chen H, Xia M, Lin M, Yang H, Kuhlenkamp J, Li T, Sodir NM, Chen YH, Josef-Lenz H, Laird PW, Clarke S, Mato JM, Lu SC (2007). Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology 133(1):207-218.
Crossref

Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC (2008). The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230-233.
Crossref

Dago DN, Claudio S, Antonio R, DomenicoM, Giorgio G, Giovanni N, Maria R, Francesca R, Roberta T, Alessandro W (2015). Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells. BMC Genomics 16(367):1-13.
Crossref

Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J (2004). Bioconductor: open software development for computational biology and bioinformatics Genome Biol. 5(10):1-39.
Crossref

Glynn DJ, Brad TS, Douglas AH, Jun Y, Wei G, Clifford HL and Richard AL (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4:1-11.
Crossref

Grabowski PJ, Black DL (2001). Alternative RNA splicing in the nervous system. Prog. Neurobiol. 65:289-308.
Crossref

Grober OM, Mutarelli M, Giurato G, Ravo M, Cicatiello L, De Filippo MR, Ferraro L, Nassa G, Papa MF, Paris O, Tarallo R (2011). Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation. BMC Genomics 12(36):1-16.
Crossref

Jeffrey AM, Zhong W (2011). Next-generation transcriptome assembly. Nat. Rev. Genet. 12:671-682.
Crossref

Kanitz A, Gypas F, Gruber AJ, Gruber AR, Martin G and Zavolan M (2015). Comparative assessment of methods for the computational inference of transcript isoform abundance from RNAseq data. Genome Biol. 16:1-26.
Crossref

Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL (2013). TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14(4):1-13.
Crossref

Kim E, Goren A, Ast G (2008). Insights into the connection between cancer and alternative splicing. Trends Genet. 24:7-10.
Crossref

Liu J, Stevens PD, Li X, Schmidt MD, Gao T (2011). PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth. Mol. Cell. Biol. 31(24):4917-4927.
Crossref

Love MI, Huber W, Anders S (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15(12):550.
Crossref

Magnani L, Elizabeth BB, Xiaoyang Z, Mathieu L (2011). PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer PLoS Genet. 7(11):e1002368.

Moller-Levet CS, Betts GN, Harris AL, Homer JJ, West CM, Miller CJ (2009). Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis. PLoS Comput. Biol. 5(11):e1000571.
Crossref

Nassa G, Tarallo R, Ambrosino C, Bamundo A, Ferraro L, Paris O, et al. (2011). A large set of estrogen receptor beta-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cell nuclei. Proteomics 11(1):159-165.
Crossref

Pal S, Gupta R, Kim H, Wickramasinghe P, Baubet V, Showe LC, et al. (2011). Alternative transcription exceeds alternative splicing in generating the transcriptome diversity of cerebellar development. Genome Res. 21(8):1260-72.
Crossref

Pal S, Ravi G, Ramana VD (2012). Alternative transcription and alternative splicing in cancer. Pharmacol. Ther. 136:283-294.
Crossref

Paris O, Ferraro L, Grober OM, Ravo M, De Filippo MR, Giurato G, Nassa G, Tarallo R, Cantarella C, Rizzo F, Di Benedetto A (2012). Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. Oncogene 31(38):4196-206.
Crossref

R Core Team (2009). R: A language and environment for statistical computing. R Foundation for Statistical Computing. URL 

View.

Rehrauer H, Opitz L, Tan G, Sieverling L, Schlapbach R (2013). Blind spots of quantitative RNA-seq: the limits for assessing abundance, differential expression, and isoform switching. BMC Bioinformatics 14:370.
Crossref

Stephen WH, James CM (2016). Detection and visualization of differential splicing in RNA-Seq data with JunctionSeq. Nucleic Acids Res. 44(15):1-15.

Sultan M, Schulz MH, Richard H, Magen A, Klingenhoff A, Scherf M, Seifert M, Borodina T, Soldatov A, Parkhomchuk D, Schmidt D (2008). A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 321:956-960.
Crossref

Tarallo R, Bamundo A, Nassa G, Nola E, Paris O, Ambrosino C, Facchiano A, Baumann M, Nyman TA, Weisz A (2011). Identification of proteins associated with ligand-activated estrogen receptor alpha in human breast cancer cell nuclei by tandem affinity purification and nano LC-MS/MS. Proteomics 11(1):172-179.
Crossref

Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L (2013). Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol. 31(1):46-53.
Crossref

Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L (2010). Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28(5):511-515.
Crossref

Venables JP (2002). Alternative splicing in the testes. Curr. Opin. Genet. Dev.12:615-619.
Crossref

Venables PJ (2004). Aberrant and Alternative Splicing in Cancer. Cancer Res. 64:7647-7654.
Crossref

Venables,JP, Klinck R, Koh C, Gervais-Bird J, Bramard A, Inkel L, Durand M, Couture S, Froehlich U, Lapointe E, Lucier JF, Thibault P, Rancourt C, Tremblay K, Prinos P, Chabot B, Elela SA (2009). Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol.16:670-676.
Crossref

Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB (2008). Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-476.
Crossref

Winter J, Kunath M, Roepcke S, Krause S, Schneider R, Schweiger S (2007). Alternative polyadenylation signals and promoters act in concert to control tissue-specific expression of the Opitz syndrome gene MID1. BMC Mol. Biol. 8(105):1-12.
Crossref

Zerbino DR, Birney E (2008).Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res.18(5):821-829.
Crossref

Zhang ZH, Jhaveri DJ, Marshall VM, Bauer DC, Edson J, Narayanan RK, Robinson GJ, Lundberg AE, Bartlett PF, Wray NR, Zhao QY (2014). A comparative study of techniques for differential expression analysis on RNA-Seq data. PLoS One 9(8):e103207.
Crossref